| Product Name | Amyloid Beta Pyroglutamate 3-42 Pre-formed Fibrils | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Description |
Human Amyloid Beta Pyroglutamate 3-42 PFFs |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Applications | WB, In vivo Assay, In vitro Assay | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Concentration | 1 mg/ml | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Conjugates |
No tag
StreptavidinProperties:
Biotin
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nature | Synthetic (TFA preparation, HFIP treated precursor) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Species | Human | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Expression System | Synthetic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Amino Acid Sequence | pyroEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Purity | >95% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Resources | Sonication Protocol | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Protein Length | 40 amino acids | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Protein Size | 4.3 kDa | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Storage Buffer | 10mM HCl with 2% DMSO |
| Storage Temperature | -80ºC |
| Shipping Temperature | Dry Ice. Shipping note: Product will be shipped separately from other products purchased in the same order. |
| Purification | N/A |
| Cite This Product | Human Synthetic (TFA preparation, HFIP treated precursor) Amyloid Beta Pyroglutamate 3-42 Pre-formed Fibrils (StressMarq Biosciences | Victoria, BC CANADA | Catalog# SPR-492) |
| Certificate of Analysis | Protein certified >95% pure by mass spec and HPLC. Low endotoxin <2.5 EU/mL @ 1mg/mL. |
| Other Relevant Information | For best results, sonicate immediately prior to use. Refer to the Neurodegenerative Protein Handling Instructions on our website, or the product datasheet for further information. |
| Alternative Names | Aβ 3-42, Amyloid beta 3-42, Beta amyloid peptide, Abeta, Abeta peptide, Amyloid beta precursor peptide, APP, pyro abeta, pyro amyloid beta, pyroglutamate amyloid beta, AβPE3, Amyloid Beta PFFs |
| Research Areas | Alzheimer's Disease, Amyloid, Neurodegeneration, Neuroscience |
| Cellular Localization | Cell membrane, Intracellular Vesicles |
| Gene ID | 351 |
| Swiss Prot | P05067 |
| Scientific Background |
Amyloid beta (Aβ) peptides, particularly the pyroglutamate-modified variant Aβ 3-42, are increasingly recognized as key contributors to Alzheimer’s disease. This truncated form arises from post-translational modification of Aβ peptides, where the N-terminal glutamate is cyclized into pyroglutamate, enhancing hydrophobicity, resistance to degradation, and aggregation propensity. Pre-formed fibrils (PFFs) of Aβ 3-42 replicate the β-sheet-rich architecture of amyloid plaques found in Alzheimer’s brains. These fibrils exhibit heightened neurotoxicity compared to full-length Aβ 1-42, due to their increased stability and ability to seed further aggregation. Aβ 3-42 PFFs are particularly effective at inducing synaptic dysfunction, neuroinflammation, and neuronal death, making them a powerful model for studying the molecular mechanisms of disease progression. In experimental systems, Aβ 3-42 PFFs are used to investigate prion-like propagation, cellular uptake, and the impact on neuronal networks. Their relevance to human pathology supports their use in preclinical drug screening, enabling the evaluation of therapeutic agents targeting aggregation, clearance, and neuroprotection. By modeling a highly pathogenic form of Aβ, pyroglutamate 3-42 PFFs provide a robust and translationally relevant platform for advancing Alzheimer’s disease research and accelerating the development of effective interventions. StressMarq's Amyloid Beta Pyroglutamate 3-42 (pyro Aβ) Pre-formed Fibrils are generated from Amyloid Beta Peptide 3-42 pre-treated with 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) using a previously published method (1,2). StressMarq's pyro Aβ3-42 fibrils present as primarily long strands when observed under TEM and AFM, and have a unique high molecular weight signal on a Western Blot with an anti-amyloid beta antibody. |
| References |
1. Stine et al. 2003. JBC. 278(13):11612-22; doi: 10.1074/jbc.M210207200 2. Chromy et al. 2003. Biochemistry. 42:12749-12760; doi: 10.1021/bi030029q 3. Panza et al. 2019. Nat Rev Neurol. 15:73-88; https://doi.org/10.1038/s41582-018-0116-6 4. Valverde et al. 2021. JBC. 297:100963; https://doi.org/10.1016/j.jbc.2021.100963 5. Schilling et al. 2008. Nat Med. 14:1106-11; DOI: 10.1038/nm.1872 6. Hartlage-Rubsamen et al. 2011. Acta Neuropathol. 121:705-19; 10.1007/s00401-011-0806-2 7. Xu, Wang and Wu. 2021. J Med Chem. 64:6549–65; DOI: 10.1021/acs.jmedchem.1c00325 8. Bayer. 2021. Nat Mol Psych. 27:1880-1885; https://doi.org/10.1038/s41380-021-01409-2 |
TEM of amyloid beta pyroglutamate 3-42 fibrils (catalog# SPR-492). Negative stain transmission electron microscopy images acquired at 80 Kv on carbon coated 400 mesh copper grids using phosphotungstic acid and uranyl acetate stain. Scale bar = 500, 200 and 100 nm (left to right). Method: Samples were prepared for examination in the transmission electron microscope using the ‘direct application method’ (Doane and Anderson 1987).
AFM of amyloid beta pyroglutamate 3-42 fibrils (catalog# SPR-492). Atomic force microscopy analysis of 1.0 mg/mL samples diluted to 0.1 mg/mL in 2% DMSO + 10 mM HCl, mounted on freshly cleaved mica, washed, dried and analyzed with tapping mode. Representative images are 10 x 10 µm x-y (left) and 5 x 5 µm x-y (middle) and 2 x 2 µm x-y (right), all with a z-range of 6 nm.
Western blot of amyloid beta pyroglutamate 3-42 fibrils (catalog# SPR-492) using anti-amyloid beta 6E10 antibody. Amyloid beta pyroglutamate 3-42 at 160 pmol was run on 4-12% Bis-Tris SDS-PAGE, transferred to nitrocellulose in the presence of 0.02% v/v Tween-20, and blotted with 1:1000 mouse 6E10 primary antibody (Biolegend). Compared to monomers re-suspended in 2% DMSO and immediately run on SDS-PAGE, fibrils show monomer depletion, a signal from 37 kDa upwards and a distinct signal in the stacking gel. MW ladder = Precision Plus Dual Xtra prestained standards.
Reviews
There are no reviews yet.